
Rumors are growing on social networks about the pharmacy crisis covering the country: they say that the prices for medicines are growing uncontrollably - sometimes almost 2-4 times, indispensable drugs disappear from the sale - some imported vital drugs are no longer anywhere and can’t get it. Unscrupulous representatives of the pharmacy business and sanctions are accused of everything.
COLTA . Ru I contacted the directors of Moscow pharmacies and pharmacists to find out how and why medicines are valued.
Director for Commerce of the Pharmacy and Orthopedic Salons network "Yuna Vita"
Since January, prices have risen by 10-15%. Everything is tied to the ruble course - and nothing more. But, as always, they found the extreme - pharmacies. Recently, I watched the plot on the first channel that, they say, pharmacies raised prices by 400% compared to the average price. And what does the average price mean? Not a single specific fact!
We purchase goods from distributors, the main part is vital drugs, the list and prices of which are fixed by the state. Moreover, at all three levels: the manufacturer, supplier and the final link - a pharmacy. No one can exceed the established margin. This is strictly monitored. For everything else - dietary supplements, medical products, mineral water, medicinal herbs and so on - each network independently regulates prices. Of course, the owner of the pharmacy can try to lift prices at least 1000%to these positions, but he simply will not be able to sell anything. The market itself regulates pricing.
For each No-ShPU there is our domestic drotaverin.
Head of the pharmacy network
We have not changed our margin since November last year. They did not overestimate their remnants in the warehouses and did not try to reach them to the prices of new deliveries. And some drugs were even forced to reduce the margin due to the fact that they are very expensive. The manufacturer raises the price of them, and the consumer simply stops buying them from us.
Raising the price of medicines is associated with the growth of the receipt price from the supplier. On average, the price increased by 11-16%. Including domestic medicines. We work with suppliers who are the first to absorb drugs from abroad, so an increase in the price of 11-16% is not as large as if we worked with suppliers who dug medicines for each other.
Our pharmacy network has been working for 15 years - we won its buyer, and, of course, it would be great to lift prices and provoke his departure.
Some more time will pass, and the price of drugs will increase sharply.
Director of the company for the production and wholesale trade of medical devices "Avran-LK"
Now in the warehouses of the pharmaceuticals there is a decrease in commodity residues purchased at old prices. The distributors are still using commodity residues that were purchased and paid at a lower rate. At the moment, all drugs and medical products have already risen in price somewhere by 30%, and somewhere by 40-50%. Even domestic production - because the so -called substances, active substances, are purchased abroad for them. That is, for dollars. And no matter where - in Germany or China.
The price is averaged, because of this its growth is not so noticeable. Some more time will pass - a quarter, a maximum of six months - and the price will increase sharply. She will approach the real dollar rate.
The sanctions of drugs did not affect. The main reason is the general economic decline in our country.
About 80% of our pharmaceutical market is import. When the manufacturer imports products into our country, the currency component in the price of the goods is 100%. Our market is so arranged that the distributor, selling goods through auctions to hospitals or retail, uses a deferred payment. From two weeks to six months. This means that today I purchase a tablet for the dollar and sell for one and a half at the current rate - 65 rubles per dollar. A wonderful margin, it would seem, but in a month, when I will have to pay for this dollar, it will cost 90 rubles. Plus, salary fund, production costs, rent, etc. That is why the inspection company is trying to put maximum risks into the price, because no one knows when economic instability will end and how else the dollar grows. But the divistor company understands that it is impossible to incite the price of medicines to infinity, otherwise the demand will simply fall.
About 80% of our pharmaceutical market is import.
A retail buyer is a grandmother who buys a set of preventive pills for her pension. If prices will grow sharply, it will stop buying and enduring them. Therefore, businessmen are afraid to import medicines in the same volume. They do not know how to do tomorrow - at what price to sell. The market in the market remains less, and it becomes much more expensive. So the deficit is formed.
At the end of last year, I read the reports of analysts of the pharmaceutical market. They believed that prices for 2015 would be on average 15-20%. Given the increase in prices, sales will be redistributed towards cheaper analogues. And at the beginning of the year, a number of drugs may occur, due to the fact that the old import contracts have already ended, and the new ones are still at the stage of imprisonment.
In fact, what is happening now is an annual story. There is nothing unusual here. A new contract is always more expensive than the past. Previously, the annual growth was around 3-7%, now 10-15%. At the beginning of the year, there are always some small interruptions with the assortment of goods. For example, in the first two weeks of January, we could not buy saline, then bought. Why this happened, no one knows. This is a working situation. So for any no-shpa and analgin you do not need to run anywhere. In addition, for each No-ShPU there is our domestic drotaverin.
Do not scare and stock up on pills.
There will be no total drug deficiency. There will be no empty shelves, as in the nineties. Do not scare and stock up on pills. It will be the same as with cheeses - there will be more than one variety, so another. But there will be fewer - both rare, orphanes, and ordinary drugs, starting with aspirin and ending with dietary supplements. The assortment will decrease - that's all. Do not have to go to Lithuania or Germany for orphan medicines. They will just cost much more. Those who need them will have to spend more time searching or significantly more money for purchase. But do not forget that everything will rise in price - communal apartment, electricity, transportation. So far, they have not touched their prices. Everyone still suffers, hold prices. However, growth will be, and will be significant.
Many imported original drugs have domestic analogues. We build our assortment in such a way that the buyer, coming to the pharmacy, has a choice - buy an expensive foreign drug or a cheap domestic analogue with the same active substance. However, the demand for Russian analogues is below imported originals. As practice shows, for some buyers, the cost of goods is a determining factor, while for others, the habit of a particular drug is important, including a more expensive imported agent. The client wants to buy an original, proven drug, which has long been on the market. It is possible that now, due to the current economic situation, there will be an increase in sales of our medicines.
There will be no empty shelves, as in the nineties.
There are analogues in Russia, but not all. The most serious drugs are diabetic, oncological, used for organs transplantation - mainly imported. If you ask the doctors, then they will probably say that you need to take only imported ones. Despite the fact that the chemical formula is the same, the synthesis and purification are different. The manufacturer plays a large role. Ours, of course, strive to increase the level of production. Some plants have already received GMP . Moreover, in the bulk, it is still imported raw materials.
Our analog tablets, the so-called generics, are still of poor quality. I do not want to say that all Russian products are of low quality. There are very good medicines, but basically we get medicines through imports. We have not developed the pharmaceutical industry. At the moment, the situation is such that producing in Southeast Asia (China, Korea, Malaysia, Philippines) at its plants or in contract production and bring to Russia is cheaper than to produce here. Why produce 2 rubles here, when you can bring 1.5 rubles and sell 1.7? This is the most important trouble, in my opinion.
Imagine the situation: a vital drug produces an imported supplier, and his price due to growth in the course rose so that it exceeds the price determined by our state. The manufacturer is simply unlucky here. So, patients will not receive this drug. In this matter, the help of the state is necessarily needed. Perhaps the state should refund the difference in value. Because otherwise we will be left without imported vital drugs.
The state is engaged in heavy system drugs - it allocates money for this. Such drugs have nothing to do with the pharmacy segment. Let's hope that situations when there will be no drugs for serious illnesses will never happen. Because this is some kind of crime against humanity.
The latest government initiatives are big strokes both in the market and in general for the health of our compatriots.
Rare drugs will grow sharply in price, but their stocks will remain. Plus someone will definitely speculate. Believe me, manufacturers, understanding how our market works, are made to great concessions. At the request of the distributors, conditions for deferred payment and the cost of products are reviewed. It is not worthless to anyone when the market falls. After all, the manufacturer also has plans for sales, and when the market falls, then everyone is bad. Everyone is trying to look for a compromise.
In the long run - it is necessary to develop our production. To do this, you need to protect the pharmaceutical industry. Now we are dependent on imports.
But the main problem is in misunderstanding the situation in the market and in the economy by our government. Their last initiatives - the reform of healthcare, budgetary reductions - these are strong blows both in the market and in general for the health of our compatriots. I understand that the state is trying to save, because there is no money. But somehow thoughtlessly.
For any business, as for a person, planning is necessary. Now it is not clear to anyone how the authorities will fight the crisis and straighten the country's economy. The business does not represent when the crisis ends. When the business understands this, then it will become a little easier.